Efficacy of contrast-enhanced ultrasound-guided percutaneous microwave ablation treatment of renal carcinomas

doi:10.3877/cma.j.issn.1672-6448.2015.04.014

Abstract

Abstract:

Objective

To assess the safety and efficacy of contrast-enhanced ultrasound (CEUS)-guided percutaneous microwave ablation (MWA) treatment of renal carcinomas.

Methods

Fifteen patients with 17 renal tumors were retrospectively analyze. The patients’ ages were in the range of 46-80 years (65.2±9.4 years), the tumor diameters were in the range of 1.1-3.9 cm (2.3±0.7 cm) and biopsy pathological results were renal cell carcinoma. All of the tumors were inconspicuous on conventional ultrasound, while conspicuous on contrast enhanced-computed tomography (CT) or magnetic resonance imaging (MRI). Seventeen tumors were ablated under the guidance of CEUS.

Results

All tumors were successfully visualized on CEUS and MWA was performed under CEUS guidance. The durations of energy application for each tumor were in the range of 5-11 min (mean ± SD 7.3±2.2 min). The mean session of CEUS-guided MWA for each tumor was 1.1±0.3. All patients were followed up for 3-49 months (median, 17 months) to observe the therapeutic effects and complications. There was no local tumor progress and major complication.

Conclusion

CEUS-guided PMWA is a safety, efficient and feasible therapy for patients with RCC which is inconspicuous on conventional US.

Key words: Kidney neoplasms, Contrast media, Ablation techniques

Chaonan Chen, Ping Liang, Xiaoling Yu, Zhigang Cheng, Zhiyu Han, Jie Yu, Fangyi Liu. Efficacy of contrast-enhanced ultrasound-guided percutaneous microwave ablation treatment of renal carcinomas[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2015, 12(04): 325-329.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://chaosheng.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1672-6448.2015.04.014

https://chaosheng.cma-cmc.com.cn/EN/Y2015/V12/I04/325

Figures/Tables 3

References 17

[1]	Jemal A,Siegel R,Ward E, et al. Cancer statistics[J]. CA Cancer J Clin, 2007, 57(1): 43-66.
[2]	张义侠,王雪梅,王毅, 等. 常规超声、超声造影及增强CT对肾恶性肿瘤诊断的比较[J]. 中国超声医学杂志, 2011, 27(12): 1109-1110.
[3]	Lackey L 2nd,Peterson C,Barr RG. Contrast-enhanced ultrasound-guided radiofrequency ablation of renal tumors[J]. Ultrasound Q, 2012, 28(4): 269-274.
[4]	Yu J,Liang P,Yu XL, et al. US-guided percutaneous microwave ablation of renal cell carcinoma: intermediate-term results[J]. Radiology, 2012, 263(3): 900-908.
[5]	Yu J,Liang P,Yu XL, et al. US-guided percutaneous microwave ablation versus open radical nephrectomy for small renal cell carcinoma: intermediate-term results[J]. Radiology, 2014, 270(3): 880-887.
[6]	Zhang XY,Luo Y,Wen TF, et al. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment[J]. World J Gastroenterol, 2014, 20(35): 12628-12636.
[7]	Li X,Liang P,Yu J, et al. Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma[J]. Radiol Oncol, 2013, 47(4): 398-404.
[8]	Hoeffel C,Pousset M,Timsit MO, et al. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour[J]. Eur Radiol, 2010, 20(8): 1812-1821.
[9]	Spârchez Z,Radu P,Zaharia T, et al. Contrast enhanced ultrasound guidance: a new tool to improve accuracy in percutaneous biopsies[J]. Med Ultrason, 2010, 12(2): 133-138.
[10]	Yoon SH,Lee KH,Kim SY, et al. Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound[J]. Eur Radiol, 2010, 20(8): 2047-2056.
[11]	Di Vece F,Tombesi P,Ermili F, et al. Contrast-enhanced ultrasound (CEUS) and CEUS-guided biopsy in the diagnosis of lung abscess in a patient with achalasia: Case report[J]. Interv Med Appl Sci, 2013, 5(1): 31-33.
[12]	Sparchez Z,Radu P,Kacso G, et al. Contrast-enhanced ultrasound guided biopsy of superficial toraco-abdominal and neck lesions. Initial experience in 20 patients[J]. Med Ultrason, 2012, 14(4): 288-293.
[13]	Kim AY,Lee MW,Rhim H, et al. Pretreatment evaluation with contrast-enhanced ultrasonography for percutaneous radiofrequency ablation of hepatocellular carcinomas with poor conspicuity on conventional ultrasonography[J]. Korean J Radiol, 2013, 14(5): 754-763.
[14]	李伯堂,金晓武,李笑弓. 超声造影对小肾癌的诊断价值[J]. 临床医学, 2012, 32(3): 36-37.
[15]	刘春英,王晓芳,谢晴, 等. 肾脏占位病变的超声造影诊断及鉴别诊断[J]. 临床超声医学杂志, 2011, 30(8): 524-526.
[16]	Zhao X,Wang W,Zhang S, et al. Improved outcome of percutaneous radiofrequency ablation in renal cell carcinoma: a retrospective study of intraoperative contrast-enhanced ultrasonography in 73 patients[J]. Abdom Imaging, 2012, 37(5): 885-891.
[17]	Carrafiello G,Mangini M,Fontana F, et al. Single-antenna microwave ablation under contrast-enhanced ultrasound guidance for treatment of small renal cell carcinoma: preliminary experience[J]. Cardiovasc Intervent Radiol, 2010, 33(2): 367-374.

Please choose a citation manager

Content to export